封面
市场调查报告书
商品编码
1547504

全球干眼症治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Dry Eye Disease Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 170 Pages | 商品交期: 最快1-2个工作天内

价格

全球干眼症治疗市场需求预计将从2023年的59.9亿美元达到2032年近89.4亿美元的市场规模,2024-2032年研究期间复合年增长率为4.55%。

干眼症是一个术语,定义感染者眼睛表面缺乏润滑或水分。这是一种常见的疾病,几乎可以影响任何人。干眼症的症状很多,包括疼痛和灼热感、眼睛发红、眼睛疲劳、眼睛发痒、畏光、眼睛酸痛、流泪等。 、吸烟、LASIK 眼科手术、荷尔蒙替代疗法等。

市场动态

过度使用智慧型手机和电脑、人口老化(极易患有干眼症)以及其他风险因素正在主导干眼症治疗市场。根据《2019 年世界人口展望》估计,全球约 9% 的人口年龄在 65 岁以上,到 2050 年,这一比例预计将占全球人口的近 17%。患有糖尿病、甲状腺疾病、红斑性狼疮、硬皮症、干燥症、类风湿性关节炎等疾病的人罹患干眼症的风险很高。这些疾病盛行率的扩大往往会导致干眼症发生率的上升。意识水平的提高、诊断率的提高、更好的治疗选择的可用性是促进市场成长的其他因素。然而,患者自我药疗的盛行以及对干眼症的认识较低可能会成为市场的限制。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球干眼症治疗市场的各个细分市场进行了包容性评估。干眼症治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

干眼症治疗市场报告的这一部分提供了有关国家和区域层面细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 人工泪液
  • 抗发炎(环孢素、皮质类固醇、其他)
  • 泪点塞
  • 秘密煽动者
  • 其他的

按疾病分类

  • 蒸发性干眼症
  • 水样干眼症

按配销通路

  • 医院药房
  • 零售药局
  • 网路药局

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲干眼症治疗市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。干眼症治疗市场的主要参与者包括诺华公司、艾尔建、Bausch Health Companies Inc.、参天製药有限公司、OASIS Medical。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:干眼症治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按疾病分类的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球干眼症治疗市场分析:依产品分类

  • 概述(按产品)
  • 按产品分类的历史和预测资料分析
  • 人工泪液
  • 抗发炎(环孢素、皮质类固醇、其他)
  • 泪点塞
  • 秘密煽动者
  • 其他的

第 6 章:全球干眼症治疗市场分析:依疾病分类

  • 按疾病分类概述
  • 按疾病分类的历史和预测资料分析
  • 蒸发性干眼症
  • 水样干眼症

第 7 章:全球干眼症治疗市场分析:按分销管道

  • 配销通路概述
  • 按配销通路进行历史和预测资料分析
  • 医院药房
  • 零售药局
  • 网路药局

第 8 章:全球干眼症治疗市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 9 章:干眼症治疗公司的竞争格局

  • 干眼症治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 10 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Novartis AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Allergan
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bausch Health Companies Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Santen Pharmaceutical Co. Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • OASIS Medical
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资讯和最新发展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR11215140

The global demand for Dry Eye Disease Treatment Market is presumed to reach the market size of nearly USD 8.94 Billion by 2032 from USD 5.99 Billion in 2023 with a CAGR of 4.55% under the study period 2024-2032.

Dry eye disease is a term that defines the lack of lubrication or moisture on the surface of the infected person's eyes. It is a usually occurring disease that can affect almost anyone. Numerous dry eye symptoms include aching and burning sensations, red eyes, tired eyes, itchy eyes, photophobia, sore eyes, watery eyes, etc. Factors causing dry eye syndrome include excessive computer uses, allergies, aging, menopause, smoking, LASIK eye surgery, hormone replacement therapy, etc.

MARKET DYNAMICS

Excessive use of smartphones & computers, expanding aging population, which is highly prone to the syndrome, and other risk factors are steering the dry eye disease treatment market. As per World Population Prospects 2019 estimates, around 9% of the global population is over 65 years of age, and by 2050 this is expected to account for nearly 17% of the worldwide population. Individuals with diseases such as diabetes, thyroid disorders, lupus, scleroderma, Sjogren's syndrome, rheumatoid arthritis are at high risk of causing dry eye disease. Expanding prevalence of these diseases will tend to cause a rise in the incidence of dry eye disease. Increasing awareness levels, rising diagnostic rates, availability of better treatment options are other factors augmenting the market's growth. However, the prevalence of self-medication by patients and low awareness about dry eye disease are likely to act as market restraints.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Dry Eye Disease Treatment. The growth and trends of Dry Eye Disease Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Dry Eye Disease Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Artificial Tears
  • Anti-inflammatory (Cyclosporine, Corticosteroid, Others)
  • Punctal Plugs
  • Secretagogue
  • Others

By Disease

  • Evaporative Dry Eye Syndrome
  • Aqueous Dry Eye Syndrome

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Dry Eye Disease Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dry Eye Disease Treatment market include Novartis AG, Allergan, Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., OASIS Medical. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. DRY EYE DISEASE TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Disease
    • 3.7.3 Market Attractiveness Analysis By Distribution Channel
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL DRY EYE DISEASE TREATMENT MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Artificial Tears Historic and Forecast Sales By Regions
  • 5.4. Anti-inflammatory (Cyclosporine, Corticosteroid, Others) Historic and Forecast Sales By Regions
  • 5.5. Punctal Plugs Historic and Forecast Sales By Regions
  • 5.6. Secretagogue Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL DRY EYE DISEASE TREATMENT MARKET ANALYSIS BY DISEASE

  • 6.1. Overview By Disease
  • 6.2. Historical and Forecast Data Analysis By Disease
  • 6.3. Evaporative Dry Eye Syndrome Historic and Forecast Sales By Regions
  • 6.4. Aqueous Dry Eye Syndrome Historic and Forecast Sales By Regions

7. GLOBAL DRY EYE DISEASE TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 7.1. Overview By Distribution Channel
  • 7.2. Historical and Forecast Data Analysis By Distribution Channel
  • 7.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 7.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 7.5. Online Pharmacies Historic and Forecast Sales By Regions

8. GLOBAL DRY EYE DISEASE TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE DRY EYE DISEASE TREATMENT COMPANIES

  • 9.1. Dry Eye Disease Treatment Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF DRY EYE DISEASE TREATMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Novartis AG
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Allergan
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Bausch Health Companies Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Santen Pharmaceutical Co. Ltd.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. OASIS Medical
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Artificial Tears Market Sales By Geography (USD MN)
  • Anti-inflammatory (Cyclosporine, Corticosteroid, Others) Market Sales By Geography (USD MN)
  • Punctal Plugs Market Sales By Geography (USD MN)
  • Secretagogue Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Disease (USD MN)
  • Evaporative Dry Eye Syndrome Market Sales By Geography (USD MN)
  • Aqueous Dry Eye Syndrome Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Dry Eye Disease Treatment Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Dry Eye Disease Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Dry Eye Disease Treatment Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Disease
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Artificial Tears Market Sales By Geography (USD MN)
  • Anti-inflammatory (Cyclosporine, Corticosteroid, Others) Market Sales By Geography (USD MN)
  • Punctal Plugs Market Sales By Geography (USD MN)
  • Secretagogue Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Disease (USD MN)
  • Evaporative Dry Eye Syndrome Market Sales By Geography (USD MN)
  • Aqueous Dry Eye Syndrome Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.